Spatiotemporal dynamics of tumor microenvironment remodeling

Kamil Lisek(Max Delbrück Center), Ilan Theurillat(Max Delbrück Center), Tancredi Massimo Pentimalli(Max Delbrück Center), Svea Beier(Max Delbrück Center), Daniel León-Periñán(Max Delbrück Center), Anna Antonatou(Max Delbrück Center), Serafima Dubnov(Hebrew University of Jerusalem), Marion Müller(Max Delbrück Center), Florian Hubl(Max Delbrück Center), Artemis Xhuri(Max Delbrück Center), Hanna Romanowicz(Polish Mother’s Memorial Hospital Research Institute), Beata Smolarz(Polish Mother’s Memorial Hospital Research Institute), Élodie Montaudon(Institut Curie), S. I. Raimundo(Max Delbrück Center), Anca Margineanu(Max Delbrück Center), Marie Schott(Max Delbrück Center), Séverine Kunz(Max Delbrück Center), Elisabetta Marangoni(Institut Curie), Nikos Karaiskos(Max Delbrück Center), Mor Nitzan(Hebrew University of Jerusalem), Walter Birchmeier(Max Delbrück Center), Nikolaus Rajewsky(German Cancer Research Center)
bioRxiv (Cold Spring Harbor Laboratory)
July 18, 2025
Cited by 3Open Access
Full Text

Abstract

Abstract During tumorigenesis, interactions between tumor and stromal cells progressively remodel the tumor microenvironment (TME) towards pro-tumoral functions. Understanding early TME remodeling dynamics is therefore crucial for developing interceptive therapies. However, clinical samples typically provide isolated, late tumorigenesis snapshots. To overcome this limitation, we generated triple-negative breast cancer mice that develop multifocal, asynchronous tumors along a continuous luminal-to-basal transdifferentiation trajectory. Ordering spatial transcriptomes from 100+ ducts along this trajectory reveals the spatiotemporal dynamics of TME remodeling and underlying molecular mechanisms. Cancer-associated myofibroblasts (myCAFs) emerge as key players in advanced tumors, where they orchestrate pro-invasive remodeling of the tumor-stromal interface. myCAFs are conserved in patient-derived xenograft models and steer tumor trajectories towards invasive phenotypes when co-injected with tumor cells in syngeneic mice. Our study shows that temporal ordering of spatially-resolved disease snapshots unravels some of the molecular “forces” that, starting from the cell-of-origin, propel cells/microenvironments along a disease trajectory.


Related Papers